Chlorpyrifos shares stimulus properties with pentylenetetrazol as evaluated by an operant drug discrimination task.

[1]  C. Niemegeers,et al.  Theoretical and methodological considerations on drug discrimination learning , 1976, Psychopharmacologia.

[2]  F. Sánchez-Santed,et al.  Effects of chlorpyrifos in the plus‐maze model of anxiety , 2001, Behavioural pharmacology.

[3]  A. Iguchi,et al.  The elevation of plasma adrenocorticotrophic hormone and expression of c-Fos in hypothalamic paraventricular nucleus by microinjection of neostigmine into the hippocampus in rats: comparison with acute stress responses , 2001, Brain Research.

[4]  M. Zarrindast,et al.  Involvement of adrenergic and cholinergic systems in nicotine-induced anxiogenesis in mice. , 2000, European journal of pharmacology.

[5]  G. Pearce,et al.  Adverse effects associated with the use of donepezil in general practice in England , 2000, Journal of psychopharmacology.

[6]  S. File,et al.  The Role of the Dorsal Hippocampal Serotonergic and Cholinergic Systems in the Modulation of Anxiety , 2000, Pharmacology Biochemistry and Behavior.

[7]  S. File,et al.  Time-course of changes in the social interaction test of anxiety following acute and chronic administration of nicotine. , 1999, Behavioural pharmacology.

[8]  T. E. Thiele,et al.  Insular cortex lesions and taste aversion learning: effects of conditioning method and timing of lesion , 1999, Brain Research.

[9]  M. van Gemert,et al.  Expert panel report of human studies on chlorpyrifos and/or other organophosphate exposures. , 1999, Journal of toxicology and environmental health. Part B, Critical reviews.

[10]  S. File,et al.  Modulation of behaviour on trials 1 and 2 in the elevated plus-maze test of anxiety after systemic and hippocampal administration of nicotine , 1999, Psychopharmacology.

[11]  O. Felician,et al.  The neurobiology and pharmacotherapy of Alzheimer's disease. , 1999, The Journal of neuropsychiatry and clinical neurosciences.

[12]  S. File,et al.  Bimodal modulation by nicotine of anxiety in the social interaction test: role of the dorsal hippocampus. , 1998, Behavioral neuroscience.

[13]  M. Brown,et al.  Review of health consequences from high‐, intermediate‐ and low‐level exposure to organophosphorus nerve agents , 1998, Journal of applied toxicology : JAT.

[14]  P. Blandina,et al.  The acetylcholine, GABA, glutamate triangle in the rat forebrain , 1998, Journal of Physiology-Paris.

[15]  M. Le Moal,et al.  Prenatal Stress Enhances Stress- and Corticotropin-Releasing Factor-Induced Stimulation of Hippocampal Acetylcholine Release in Adult Rats , 1998, The Journal of Neuroscience.

[16]  L. Ferraro,et al.  Inhibitory cholinergic control of endogenous GABA release from electrically stimulated cortical slices and K+-depolarized synaptosomes , 1997, Neurochemistry International.

[17]  R. Fenske,et al.  Long-term use of organophosphates and neuropsychological performance. , 1997, American journal of industrial medicine.

[18]  A. Maelicke,et al.  Paraoxon: cholinesterase-independent stimulation of transmitter release and selective block of ligand-gated ion channels in cultured hippocampal neurons. , 1996, The Journal of pharmacology and experimental therapeutics.

[19]  T. Parrón,et al.  Increased risk of suicide with exposure to pesticides in an intensive agricultural area. A 12-year retrospective study. , 1996, Forensic science international.

[20]  H. Fibiger,et al.  Conditioned and Unconditioned Stimuli Increase Frontal Cortical and Hippocampal Acetylcholine Release: Effects of Novelty, Habituation, and Fear , 1996, The Journal of Neuroscience.

[21]  A. Spurgeon,et al.  Neuropsychological effects of long-term exposure to organophosphates in sheep dip , 1995, The Lancet.

[22]  G. Biggio,et al.  Modulation of basal and stress-induced release of acetylcholine and dopamine in rat brain by abecarnil and imidazenil, two anxioselective gamma-aminobutyric acidA receptor modulators. , 1995, The Journal of pharmacology and experimental therapeutics.

[23]  D. Overstreet,et al.  The role of acetylcholine mechanisms in mood disorders , 1995 .

[24]  G. Biggio,et al.  The benzodiazepine receptor antagonist flumazenil increases acetylcholine release in rat hippocampus , 1994, Brain Research.

[25]  D. Benjamin,et al.  Anxiogenic effect of disulfiram evaluated in an animal model. , 1993, Journal of studies on alcohol.

[26]  N. Leidenheimer,et al.  Inverse agonist properties of the FG 7142 discriminative stimulus , 1991, Pharmacology Biochemistry and Behavior.

[27]  C. Pope,et al.  Comparison of in vivo cholinesterase inhibition in neonatal and adult rats by three organophosphorothioate insecticides. , 1991, Toxicology.

[28]  M. Raiteri,et al.  Muscarinic receptors mediating inhibition of gamma-aminobutyric acid release in rat corpus striatum and their pharmacological characterization. , 1990, The Journal of pharmacology and experimental therapeutics.

[29]  H. Lal,et al.  Diazepam tolerance and withdrawal assessed in an animal model of subjective drug effects , 1987 .

[30]  G. Pepeu,et al.  Changes in cortical acetylcholine output induced by modulation of the nucleus basalis , 1986, Brain Research Bulletin.

[31]  D. Nutt.  Benzodiazepine dependence in the clinic: reason for anxiety? , 1986 .

[32]  D. Stephens,et al.  β-Carbolines with agonistic and inverse agonistic properties at benzodiazepine receptors of the rat , 1984, Neuroscience Letters.

[33]  H. Lal,et al.  Antagonism of discriminative stimuli produced by anxiogenic drugs as a novel approach to bioassay anxiolytics , 1984 .

[34]  H. Lal,et al.  Behavioral analogues of anxiety animal models , 1983, Neuropharmacology.

[35]  S. D. Murphy,et al.  Kinetic analyses of the microsomal biotransformation of the phosphorothioate insecticides chlorpyrifos and parathion. , 1983, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[36]  H. Levin,et al.  Anxiety associated with exposure to organophosphate compounds. , 1976, Archives of general psychiatry.

[37]  H. Calhoun,et al.  Metrazol tolerance in a "normal" volunteer population. A ten year follow-up report. , 1970, The Journal of nervous and mental disease.

[38]  J. Holmes,et al.  EEG, PSYCHOLOGICAL, AND NEUROLOGICAL ALTERATIONS IN HUMANS WITH ORGANOPHOSPHORUS EXPOSURE * , 1969, Annals of the New York Academy of Sciences.

[39]  E. Rodin.  Metrazol tolerance in a normal voluntser population; an investigation of the potential significance of abnormal findings. , 1958, Electroencephalography and clinical neurophysiology.